flavanol
Botanicalexperimental
Flavan-3-ols are a subgroup of flavonoids. They are derivatives of flavans that possess a 2-phenyl-3,4-dihydro-2H-chromen-3-ol skeleton. Flavan-3-ols are structurally diverse and include a range of compounds, such as catechin, epicatechin gallate, epigallocatechin, epigallocatechin gallate, proanthocyanidins, theaflavins, thearubigins. They play a part in plant defense and are present in the majority of plants. — Wikipedia
Clinical trial activity
16 trials · 15 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 29, 2008 (NCT01483508)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaFlavan-3-ol ↗
Also known as
- flavanol
- flavanol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06812689 | N/A | Nov 26, 2022 | Necmettin Erbakan University, The Scientific and Technological Research Council of Turkey |
| NCT04907097 | N/A | Nov 30, 2021 | Campus Venlo, CEP Group Holding B.V., Maastricht University, VieCuri Medical Centre |
| NCT05782309 | N/A | Apr 1, 2019 | University of Duesseldorf |
| NCT03723694 | N/A | Jan 1, 2019 | Columbia University |
| NCT03722199 | N/A | Sep 1, 2018 | Ghent University |
| NCT03488823 | N/A | Nov 1, 2017 | University of Duesseldorf |
| NCT03526094 | N/A | May 5, 2016 | Mars, Inc., University of California, Davis |
| NCT02728466 | N/A | Oct 1, 2014 | University of Duesseldorf |
| NCT02243956 | N/A | Jan 31, 2014 | Anti-Diabetic Food Centre, Lund University |
| NCT02147223 | N/A | Nov 1, 2013 | University of Duesseldorf |
| NCT01799005 | N/A | Feb 1, 2013 | University of Duesseldorf |
| NCT02520466 | N/A | Jul 1, 2012 | University of Zurich |
| NCT01639781 | Phase 1 | Nov 1, 2011 | University of Duesseldorf, University of Reading |
| NCT02149238 | N/A | Feb 1, 2011 | University of Duesseldorf |
| NCT01180127 | Phase 2 | Dec 1, 2009 | Columbia University, Mars, Inc. |
| NCT01483508 | N/A | Feb 29, 2008 | University of California, Davis |
Showing 16 of 16 trials
Page 1 / 1
Organizations
Research & Development (15)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Duesseldorf | Academic/Hospital | 7 | 7 | 2 | 2011 |
| Columbia University | Academic/Hospital | 2 | 2 | 2 | 2009 |
| Mars, Inc. | For profit | 2 | 0 | 2 | 2009 |
| University of California, Davis | Academic/Hospital | 2 | 2 | 1 | 2008 |
| Anti-Diabetic Food Centre | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Campus Venlo | Academic/Hospital | 1 | 0 | 1 | 2021 |
| CEP Group Holding B.V. | For profit | 1 | 0 | 1 | 2021 |
| Ghent University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Lund University | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Maastricht University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Necmettin Erbakan University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| The Scientific and Technological Research Council of Turkey | Government | 1 | 0 | 1 | 2022 |
| University of Reading | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Zurich | Academic/Hospital | 1 | 1 | 1 | 2012 |
| VieCuri Medical Centre | Academic/Hospital | 1 | 0 | 1 | 2021 |
15 organizations
Page 1 / 1